Dr. Reddy's Laboratories SAS
1 clinical trials · Sponsor
◉ Watch Dr. Reddy's Laboratories SAS
| Record | Firm | Date |
|---|---|---|
| Effectiveness and Safety of Fulvestrant in Postmenopausal Women With Advanced Breast Cancer HR+, HER2- (NCT05140655) | Dr. Reddy's Laboratories SAS | 2021-04-19 |
Track Dr. Reddy's Laboratories SAS automatically
Every clearance here is in the API, with alerts when new ones post.